e-learning
resources
London 2016
Monday, 05.09.2016
Community-acquired pneumonia: risk classes and management issues
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia
Ian Webster (Lancashire, United Kingdom), Olivia George, Ian Webster
Source:
International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Session:
Community-acquired pneumonia: risk classes and management issues
Session type:
Thematic Poster
Number:
2580
Disease area:
Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Ian Webster (Lancashire, United Kingdom), Olivia George, Ian Webster. Effect of adherence to guidelines on mortality, length of stay and critical care admission in community-acquired pneumonia. Eur Respir J 2016; 48: Suppl. 60, 2580
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
Predictive indexes in prolonged weaning of mechanical ventilation due to tracheostomy in patients with COVID-19 pneumonia
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Related content which might interest you:
Effect of giving antibiotics within 4 hours to patients with community-acquired pneumonia on mortality, length of stay and critical care admission
Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment
Year: 2016
Efficacy of ceftobiprole in intensive care unit (ICU) patients with hospital-acquired pneumonia (HAP)
Source: International Congress 2014 – Respiratory infections: inflammation and treatment
Year: 2014
A study of antibiogram assay, risk factors and etiology of ventilator associated pneumonia (VAP) in a tertiary care hospital of Pakistan
Source: Annual Congress 2013 –Antibiotics, resistance and vaccines
Year: 2013
Severe community-acquired pneumonia in alcoholic patients hospitalized in intensive care unit
Source: International Congress 2016 – Community-acquired pneumonia: risk classes and management issues
Year: 2016
The treatment costs of ventilator associated pneuomonia in intensive care unit
Source: International Congress 2015 – Immunodepression and severe pneumonia
Year: 2015
The impact of a delay in intensive care unit admission for community-acquired pneumonia
Source: Eur Respir J 2010; 36: 826-833
Year: 2010
Impact of a intensive care unit (ICU) programme to improve compliance with hand hygiene in ventilator associated pneumonia (VAP) incidence
Source: Annual Congress 2009 - Ventilator-associated pneumonia, severe community-acquired pneumonia and healthcare associated pneumonia
Year: 2009
Studying the association between mortality in patients requiring hospital admission for Community Acquired Pneumonia and pre-hospital antibiotic treatment in primary care
Source: International Congress 2017 – Discussion of vaccines, biomarkers and risk factors analysis
Year: 2017
Implementation of ERS guidelines for the management of adult community-acquired pneumonia in a primary care hospital
Source: Eur Respir J 2001; 18: Suppl. 33, 503s
Year: 2001
Follow up of asthmatic patients after admission to intensive care unit (ICU) due to an acute exacerbation
Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations
Year: 2013
Epidemiology and outcome of ventilator associated pneumonia in an tertiary care ICU of India.
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018
Hypercapnia as a marker of ICU admission and prolonged hospitalization in patients with community-acquired pneumonia
Source: International Congress 2015 – Acute critical care: news from the ICU
Year: 2015
Health care associated pneumonia requiring hospitalisation
Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients
Year: 2010
Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia
Source: Eur Respir J 2007; 29: 751-756
Year: 2007
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2012; 39: 156-162
Year: 2012
Initial management of pneumonia and sepsis: factors associated with improved outcome
Source: Eur Respir J 2011; 39: 156-162
Year: 2012
Prognostic factors of the patients admitted to intensive care unit with nursing and healthcare-associated pneumonia
Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management
Year: 2015
A severity-of-illness score for tuberculosis in the intensive care unit
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014
Incidence and mortality of pneumonia in intensive care unit patients
Source: Annual Congress 2003 - Epidemiology, therapy and outcome of infections in the ICU
Year: 2003
Characteristics and outcome of patients with active pulmonary tuberculosis requiring intensive care unit
Source: International Congress 2014 – Mycobacterium tuberculosis infection and disease: clinical epidemiology 1
Year: 2014
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept